NCT00578825Unknown不适用
A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Hospital Authority, Hong Kong9 个研究点 分布在 1 个国家目标入组 340 人开始时间: 2007年12月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 340
- 试验地点
- 9
- 主要终点
- Development of severe SARS
研究概览
简要总结
The study aims to examine whether the combination of Lopinavir/Ritonavir plus Ribavirin for treatment of severe acute respiratory syndrome (SARS) is superior to placebo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female over the age of 18 with a diagnosis of SARS and with valid consent will be recruited.
排除标准
- •Subjects with medical conditions that makes the prescription of study medications unsafe are excluded.
结局指标
主要结局
Development of severe SARS
时间窗: Any time during the acute illness
次要结局
- Adverse events(Throughout the illness period)
- SARS-CoV Viral load(Throughout the illness period)
- Immunological profile(Throughout the illness period)
研究者
研究点 (9)
Loading locations...
相似试验
已完成
3 期
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-NaiveChronic Hepatitis CNCT00230958Bausch Health Americas, Inc.900
已完成
3 期
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment NaiveChronic Hepatitis CNCT00093093Bausch Health Americas, Inc.900
已完成
不适用
The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian FederationHIV-1 InfectionNCT02581202AbbVie216
Unknown
2 期
The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention TreatmentHIV InfectionsNCT00005118Merck Sharp & Dohme LLC100
已完成
不适用
A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary SyndromeHantavirus Pulmonary SyndromeNCT00001123National Institute of Allergy and Infectious Diseases (NIAID)130